Irrespectively, targeting ANKRD1 by gene silencing and stabilized ASOs was sufficient to suppress AP-1 activity in CAFs and reverse their tumor-enhancing properties, making it a target of likely translational significance. The gene discussed is JUND; the disease is neoplasm.